These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29451744)

  • 1. Design, Synthesis, and Biological Evaluation of Bivalent Ligands Targeting Dopamine D
    Qian M; Vasudevan L; Huysentruyt J; Risseeuw MDP; Stove C; Vanderheyden PML; Van Craenenbroeck K; Van Calenbergh S
    ChemMedChem; 2018 May; 13(9):944-956. PubMed ID: 29451744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Novel Biased μ-Opioid-Receptor (μOR) Agonists.
    Ma M; Sun J; Li M; Yu Z; Cheng J; Zhong B; Shi W
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30641969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and binding profile of haloperidol-based bivalent ligands targeting dopamine D(2)-like receptors.
    Salama I; Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3753-6. PubMed ID: 25047579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis toward Bivalent Ligands for the Dopamine D
    Qian M; Wouters E; Dalton JAR; Risseeuw MDP; Crans RAJ; Stove C; Giraldo J; Van Craenenbroeck K; Van Calenbergh S
    J Med Chem; 2018 Sep; 61(18):8212-8225. PubMed ID: 30180563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homobivalent Dopamine D
    Ullmann T; Gienger M; Budzinski J; Hellmann J; Hübner H; Gmeiner P; Weikert D
    ACS Chem Biol; 2021 Feb; 16(2):371-379. PubMed ID: 33435665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers.
    Fujita W; Gomes I; Dove LS; Prohaska D; McIntyre G; Devi LA
    Biochem Pharmacol; 2014 Dec; 92(3):448-56. PubMed ID: 25261794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Bitopic Ligands as Potent Dopamine D
    Qian M; Zhou K; Wu Y; Luo Z; Xiao Z; Sun J; Zeng S; Yao Y; Zhao S; Chen X
    ChemMedChem; 2022 Feb; 17(4):e202100681. PubMed ID: 34855308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bivalent molecular probes for dopamine D2-like receptors.
    Huber D; Löber S; Hübner H; Gmeiner P
    Bioorg Med Chem; 2012 Jan; 20(1):455-66. PubMed ID: 22100258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a true bivalent dopamine D
    Qian M; Ricarte A; Wouters E; Dalton JAR; Risseeuw MDP; Giraldo J; Van Calenbergh S
    Eur J Med Chem; 2021 Feb; 212():113151. PubMed ID: 33450620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
    Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
    Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a bivalent dopamine D₂ receptor agonist.
    Kühhorn J; Götz A; Hübner H; Thompson D; Whistler J; Gmeiner P
    J Med Chem; 2011 Nov; 54(22):7911-9. PubMed ID: 21999579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights into the biased signaling mechanism of the μ-opioid receptor.
    Cong X; Maurel D; Déméné H; Vasiliauskaité-Brooks I; Hagelberger J; Peysson F; Saint-Paul J; Golebiowski J; Granier S; Sounier R
    Mol Cell; 2021 Oct; 81(20):4165-4175.e6. PubMed ID: 34433090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Biological Evaluation, and Utility of Fluorescent Ligands Targeting the μ-Opioid Receptor.
    Schembri LS; Stoddart LA; Briddon SJ; Kellam B; Canals M; Graham B; Scammells PJ
    J Med Chem; 2015 Dec; 58(24):9754-67. PubMed ID: 26632862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.
    Deekonda S; Cole J; Sunna S; Rankin D; Largent-Milnes TM; Davis P; BassiriRad NM; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem Lett; 2016 Jan; 26(1):222-7. PubMed ID: 26611918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of salsolinol, a full G
    Berríos-Cárcamo P; Rivera-Meza M; Herrera-Marschitz M; Zapata-Torres G
    Chem Biol Drug Des; 2019 Aug; 94(2):1467-1477. PubMed ID: 30920734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist.
    Sánchez-Soto M; Bonifazi A; Cai NS; Ellenberger MP; Newman AH; Ferré S; Yano H
    Mol Pharmacol; 2016 Apr; 89(4):457-66. PubMed ID: 26843180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteromer Induction: An Approach to Unique Pharmacology?
    Portoghese PS; Akgün E; Lunzer MM
    ACS Chem Neurosci; 2017 Mar; 8(3):426-428. PubMed ID: 28139906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.